COVID-19's skin secrets: could chilblains hold clues to the virus?

NCT ID NCT04344119

Recruiting now Knowledge-focused Sponsor: Centre Hospitalier Universitaire de Nice Source: ClinicalTrials.gov ↗

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This study looks at skin problems that appear during a COVID-19 infection, with a special focus on chilblains (painful red or purple bumps on fingers or toes). Researchers want to understand why these skin changes happen—whether from the virus itself, tiny blood clots, or inflammation. By studying 30 patients with confirmed COVID-19 and new skin lesions, they hope to link skin findings with blood tests and blood vessel exams to better understand the disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could clarify why some COVID-19 patients develop skin symptoms, potentially pointing to new ways to understand or manage the disease.
What could go wrong: This is a small observational study (30 people) focused on understanding, not treatment. Findings may not apply to all patients or lead to direct medical changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHILBLAINS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chilblain lupus Chilblains COVID-19 Skin Manifestations

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHILBLAINS COVID SKIN MANIFESTATIONS

Contacts and locations

Locations

CHU de Nice
RECRUITING

Nice, 06200, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.